Pharmacokinetics of CYP2C19- and CYP3A4-Metabolized Drugs in Cirrhosis Using a Whole-Body PBPK Approach. [PDF]
Mu R +5 more
europepmc +1 more source
CYP2C19 genotype and cardiovascular events.
Siasos, Gerasimos +2 more
openaire +4 more sources
Medical Marijuana and Treatment Personalization: The Role of Genetics and Epigenetics in Response to THC and CBD. [PDF]
Kalak M +3 more
europepmc +1 more source
Prevalence of <i>CYP2C19</i> Poor Metabolisers Among South Indian Psychiatric Patients: A Pharmacogenetic Perspective Toward Precision Psychopharmacology. [PDF]
Sukumaran B +6 more
europepmc +1 more source
Escitalopram Dose Optimization During Pregnancy: A PBPK Modeling Approach. [PDF]
Choi SY, Yang E, Shin KH.
europepmc +1 more source
Personalizing voriconazole dosing in Chinese hematological patients: CYP2C19 phenotype and albumin-bilirubin grade as key predictors of trough concentrations. [PDF]
Hu L, Tang X, Li Y, Huang J.
europepmc +1 more source
Family health history and pharmacogenomics show cross generation premature amitriptyline discontinuation is associated with CYP2C19 loss of-function enrichment. [PDF]
Magavern EF +4 more
europepmc +1 more source
Toward Genotype-Informed Dosing of Voriconazole: Head-to-Head Simulations Across CYP2C19 Phenotypes Using Population Pharmacokinetic Models. [PDF]
Lee Y, Lee N, Rhee SJ, Kim Y.
europepmc +1 more source
CYP2C19 Genotype-Guided Antiplatelet Therapy in Precision Medicine for Stroke. [PDF]
Zhang Q, Liu T.
europepmc +1 more source

